Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A3OF
|
|||
Former ID |
DCL000817
|
|||
Drug Name |
GMC-283
|
|||
Synonyms |
CHEMBL430798; MolPort-042-665-651; GMC-2-83; ZINC14299682; BDBM50078062; Trifluoro-methanesulfonic acid 11-(4-methyl-piperazin-1-yl)-dibenzo[b,f][1,4]oxazepin-2-yl ester
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Schizophrenia [ICD-11: 6A20] | Terminated | [1] | |
Company |
Merck KGaA
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H18F3N3O4S
|
|||
Canonical SMILES |
CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)OS(=O)(=O)C(F)(F)F
|
|||
InChI |
1S/C19H18F3N3O4S/c1-24-8-10-25(11-9-24)18-14-12-13(29-30(26,27)19(20,21)22)6-7-16(14)28-17-5-3-2-4-15(17)23-18/h2-7,12H,8-11H2,1H3
|
|||
InChIKey |
DQNCRNVCBHYBQP-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.